Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-8603
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications ; volume:10 ; number:1 ; day:10 ; month:3 ; year:2014 ; pages:1-12 ; date:12.2014
Globalization and health ; 10, Heft 1 (10.3.2014), 1-12, 12.2014
- Creator
-
Mujinja, Phares GM
Mackintosh, Maureen
Justin-Temu, Mary
Wuyts, Marc
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1744-8603-10-12
- URN
-
urn:nbn:de:101:1-2021083019280656531518
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mujinja, Phares GM
- Mackintosh, Maureen
- Justin-Temu, Mary
- Wuyts, Marc
- SpringerLink (Online service)
Other Objects (12)
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Using health markets to improve access to medicines: three case studies
Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
Differential pricing of pharmaceuticals inside Europe : exploring compulsory licenses and exhaustion for access to patented essential medicines
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
Access of high technology medicines in Russia
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe : Better access to medicines through HTA
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Using health markets to improve access to medicines: three case studies
Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
Differential pricing of pharmaceuticals inside Europe : exploring compulsory licenses and exhaustion for access to patented essential medicines
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
Access of high technology medicines in Russia
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe : Better access to medicines through HTA
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Using health markets to improve access to medicines: three case studies
Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
Differential pricing of pharmaceuticals inside Europe : exploring compulsory licenses and exhaustion for access to patented essential medicines
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
Access of high technology medicines in Russia